[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

Debruyne, F; Koch, G; Boyle, P; Da Silva, F; Gillenwater, J; Hamdy, F; Perrin, P; Teillac, P; Vela-Navarrete, R; Raynaud, J

Journal article

[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

Abstract:: OBJECTIVE: While the lipidosterolic extract (LSESr) of Serenoa repens--Permixon--has been shown to have an equivalent efficacy to finasteride in patients with benign prostatic hyperplasia (BPH), to date, there has been no valid comparison of phytotherapy with alpha-blockers. The aim of this study was to assess the equivalent efficacy of Permixon and tamsulosin. METHODS: Eight hundred and eleven men with symptomatic BPH (international prostdate symptom score, I-PSS > or = 10) were recruite...
Expand abstract
Collapse abstract

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Debruyne, F., Koch, G., Boyle, P., Da Silva, F., Gillenwater, J., Hamdy, F., Perrin, P., Teillac, P., Vela-Navarrete, R., & Raynaud, J. (2016). [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]. Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie, 12(3), 384–392.

MLA Style

Debruyne, F., et al. “[Comparison of a Phytotherapeutic Agent (Permixon) with an Alpha-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: a 1-Year Randomized International Study].” Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie, vol. 12, no. 3, 2016, pp. 384–92.

Chicago Style

Debruyne, F, G Koch, P Boyle, F Da Silva, J Gillenwater, F Hamdy, P Perrin, P Teillac, R Vela-Navarrete, and J Raynaud. 2016. “[Comparison of a Phytotherapeutic Agent (Permixon) with an Alpha-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: a 1-Year Randomized International Study].” Progres En Urologie : Journal De l'Association Francaise d'Urologie Et De La Societe Francaise d'Urologie 12 (3): 384–92.
Tweet
Print